Prevalence and Protein Specificity of Human Antibodies to Inkoo Virus Infection

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2007 Oct 19

PMID 17942611

Citations 11

Authors

Niina Putkuri

Antti Vaheri

Olli Vapalahti

Affiliations

Soon will be listed here.

Abstract

Inkoo virus (INKV), a member of the California serogroup orthobunyaviruses, is circulating widely in northern Europe. Although the virus was discovered over 40 years ago, the disease associations and immune responses in human infection are poorly characterized. We first developed an immunofluorescence assay (IFA) for the detection of INKV antibodies in humans, and then we studied a panel of 1,292 sera in patients with a febrile illness in Finland. We found four acute (immunoglobulin M [IgM] positive) INKV infections and an IgG seroprevalence of 51.3%. The data indicate that the infection has become more common than it was in the 1960s, especially in southern Finland. Two distinct IgG IFA fluorescence patterns were observed: a granular pattern in sera from patients with acute INKV infection and a diffuse pattern in those with long-standing immunity. Further analysis with a panel of INKV-positive sera (n = 18; verified by neutralization assay) of protein-specific responses, using immunoprecipitation and IFA based on baculovirus-expressed INK N, Gn, and Gc proteins, demonstrated a strong IgG response predominantly towards N protein in the acute phase. In contrast, in patients with long-standing immunity, the Gc response was more prominent and the N response was weaker. In conclusion, a diagnostic IgG IFA pattern distinguishing between acute infection and long-standing immunity was observed. N protein seems to be the optimal antigen for the serodiagnosis of acute infection, and the Gc protein could be appropriate for the serosurveillance of INKV.

Citing Articles

The Adaptive Immune Response against .

Alatrash R, Herrera B Viruses. 2024; 16(3).

PMID: 38543848 PMC: 10974645. DOI: 10.3390/v16030483.

Characterisation of the RNA Virome of Nine Species in Finland.

Truong Nguyen P, Culverwell C, Suvanto M, Korhonen E, Uusitalo R, Vapalahti O Viruses. 2022; 14(7).

PMID: 35891469 PMC: 9324324. DOI: 10.3390/v14071489.

Inkoo and Sindbis viruses in blood sucking insects, and a serological study for Inkoo virus in semi-domesticated Eurasian tundra reindeer in Norway.

Shakya R, Tryland M, Vikse R, Romano J, Asbakk K, Nymo I Virol J. 2022; 19(1):99.

PMID: 35659694 PMC: 9166600. DOI: 10.1186/s12985-022-01815-0.

Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.

Evans A, Peterson K Viruses. 2019; 11(9).

PMID: 31470541 PMC: 6784171. DOI: 10.3390/v11090794.

Differences in Neuropathogenesis of Encephalitic California Serogroup Viruses.

Evans A, Winkler C, Peterson K Emerg Infect Dis. 2019; 25(4):728-738.

PMID: 30882310 PMC: 6433036. DOI: 10.3201/eid2504.181016.

References

Butenko A, VLADIMIRTSEVA E, Lvov S, Calisher C, KARABATSOS N . California serogroup viruses from mosquitoes collected in the USSR. Am J Trop Med Hyg. 1991; 45(3):366-70. DOI: 10.4269/ajtmh.1991.45.366. View

Grady L, SRIHONGSE S, Grayson M, DEIBEL R . Monoclonal antibodies against La Crosse virus. J Gen Virol. 1983; 64 (Pt 8):1699-704. DOI: 10.1099/0022-1317-64-8-1699. View

Kingsford L, Hill D . The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization. J Gen Virol. 1983; 64 (Pt 10):2147-56. DOI: 10.1099/0022-1317-64-10-2147. View

LeDuc J . Epidemiology and ecology of the California serogroup viruses. Am J Trop Med Hyg. 1987; 37(3 Suppl):60S-68S. DOI: 10.4269/ajtmh.1987.37.60s. View

. La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology. 1985; 140(2):209-16. DOI: 10.1016/0042-6822(85)90359-9. View

Pekosz A . The extracellular domain of La Crosse virus G1 forms oligomers and undergoes pH-dependent conformational changes. Virology. 1996; 225(1):243-7. DOI: 10.1006/viro.1996.0596. View

Jacoby D, Cooke C, Prabakaran I, Boland J, NATHANSON N . Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology. 1993; 193(2):993-6. DOI: 10.1006/viro.1993.1213. View

Plassmeyer M, Soldan S, Stachelek K, Martin-Garcia J, Gonzalez-Scarano F . California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology. 2005; 338(1):121-32. DOI: 10.1016/j.virol.2005.04.026. View

BRUMMER-KORVENKONTIO M . Arboviruses in Finland. V. Serological survey of antibodies against Inkoo virus (California group) in human, cow, reindeer, and wildlife sera. Am J Trop Med Hyg. 1973; 22(5):654-61. DOI: 10.4269/ajtmh.1973.22.654. View

10.

BARDOS V, Medek M, KANIA V, Hubalek Z . Isolation of Tahyna virus from the blood of sick children. Acta Virol. 1975; 19(5):447. View

11.

Campbell W, Huang C . Sequence comparisons of medium RNA segment among 15 California serogroup viruses. Virus Res. 1999; 61(2):137-44. DOI: 10.1016/s0168-1702(99)00033-7. View

12.

Vapalahti O, Kallio-Kokko H, Narvanen A, Julkunen I, Lundkvist A, Plyusnin A . Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol. 1995; 46(4):293-303. DOI: 10.1002/jmv.1890460402. View

13.

Plassmeyer M, Soldan S, Stachelek K, Roth S, Martin-Garcia J, Gonzalez-Scarano F . Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology. 2006; 358(2):273-82. PMC: 1820767. DOI: 10.1016/j.virol.2006.08.050. View

14.

BURGDORFER W, NEWHOUSE V, Thomas L . Isolation of California encephalitis virus from the blood of a snowshoe hare (Lepus americanus) in western Montana. Am J Hyg. 1961; 73:344-9. DOI: 10.1093/oxfordjournals.aje.a120193. View

15.

BRUMMER-KORVENKONTIO M, Saikku P, Korhonen P, Ulmanen I, Reunala T, Karvonen J . Arboviruses in Finland. IV. Isolation and characterization of Inkoo virus, a Finnish representative of the California group. Am J Trop Med Hyg. 1973; 22(3):404-13. View

16.

Matsuura Y, Possee R, Overton H, Bishop D . Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J Gen Virol. 1987; 68 ( Pt 5):1233-50. DOI: 10.1099/0022-1317-68-5-1233. View

17.

Tao H, Xia S, Chan Z, Song G, Yanagihara R . Morphology and morphogenesis of viruses of hemorrhagic fever with renal syndrome. II. Inclusion bodies--ultrastructural markers of hantavirus-infected cells. Intervirology. 1987; 27(1):45-52. DOI: 10.1159/000149714. View

18.

Kingsford L, Ishizawa L, Hill D . Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology. 1983; 129(2):443-55. DOI: 10.1016/0042-6822(83)90182-4. View

19.

Pobjecky N, NATHANSON N . La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology. 1984; 132(1):222-5. DOI: 10.1016/0042-6822(84)90107-7. View

20.

Shope R, Calisher C, NATHANSON N . Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology. 1982; 120(1):42-53. DOI: 10.1016/0042-6822(82)90005-8. View